Skip to Content

Uramaxin GT Dosage

Generic name: UREA 0.45mL in 1mL
Dosage form: gel, pre-filled-applicator

See also:

Medically reviewed on April 25, 2018.

DOSAGE AND ADMINISTRATION: DIRECTIONS FOR NAILS: Apply Uramaxin (45% Urea) GT to diseased or damaged nail tissue twice per day, or as directed by a physician.

DIRECTIONS FOR SKIN: Apply Uramaxin (45% Urea) GT to affected area(s) twice per day, or as directed by a physician.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Next → Professional

More about Uramaxin GT (urea topical)

Consumer resources

Other brands: Carmol, Keralac, X-Viate, Hydro 35, ... +33 more

Professional resources

Uramaxin GT (FDA)

Other Formulations

Related treatment guides

Drug Status

Rx
OTC

Availability Rx and/or OTC

Pregnancy Category Risk cannot be ruled out

CSA Schedule* Not a controlled drug

Drug Class

Topical emollients

Related Drugs

Dermatological Disorders Temovate, Clobex, Olux, Cormax, Clobevate, Olux-E, Embeline, Clodan, More...

Dry Skin Eucerin, AmLactin, Aquaphor, Lac-Hydrin, ammonium lactate topical, urea topical, EpiCeram, CeraVe, More...

Pityriasis rubra pilaris urea topical, Carmol, lactic acid topical, Keralac, MeTopic, Uramaxin, Utopic, X-Viate, More...

Uramaxin GT Rating

No reviews - Add your review

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions and Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Oct 1st, 2018), Cerner Multum™ (updated Oct 2nd, 2018), Wolters Kluwer™ (updated Oct 2nd, 2018) and others. To view content sources and attributions, please refer to our editorial policy.